MannKind grabs scPharmaceuticals and its heart failure infuser Furoscix in $360M deal
25th August 2025 Uncategorised 0The company touts a large U.S. market opportunity for scPharmaceuticals’ Furoscix, which recently expanded into chronic kidney disease.
More: MannKind grabs scPharmaceuticals and its heart failure infuser Furoscix in 0M deal
Source: fierce
